The Effect of High Intensity Interval Training on Cardiovascular Fitness in People With Progressive Multiple Sclerosis.
1 other identifier
interventional
12
1 country
1
Brief Summary
This is a pilot trial to explore the cardiovascular of eight weeks of twice weekly high intensity interval training in people with progressive multiple sclerosis. A control group of people with progressive multiple sclerosis will undergo continuous moderate intensity exercise, twice weekly for 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2016
CompletedFirst Posted
Study publicly available on registry
November 1, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedOctober 25, 2017
October 1, 2017
8 months
October 28, 2016
October 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
heart rate max
Maximal heart rate elicited during a maximal exertion test
8 weeks
Secondary Outcomes (10)
Resting blood pressure
8 weeks
Resting heart rate
8 weeks
Brain derived neurotrophic factor
8 weeks
Lactate
8 weeks
Lipoprotein profile
8 weeks
- +5 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTAL8 weeks of twice weekly high intensity interval training. Session protocol: 2 minute warm up at nominal resistance on cycle ergometer, 6 six intervals of 80-95% heart rate max interspersed with 6 intervals of 1.5 minute working rest. Then 3 minutes cool down.
control
ACTIVE COMPARATOR8 weeks of twice weekly continuous moderate intensity exercise. Session protocol: 2 minutes warm up at nominal resistance on cycle ergometer, 20 minutes at 60-70% heart rate max. Then 3 minutes cool down.
Interventions
1.5 min intervals at 80-95% heart rate max on cycle ergometer 1.5 min intervals at nominal resistance on cycle ergometer
Eligibility Criteria
You may qualify if:
- Diagnosed with a progressive form of MS
- Aged 18 years or older
- Known to members of staff of the MS service NHS Ayrshire \& Arran
- Ability to attend Douglas Grant Rehabilitation centre twice a week for eight weeks
- EDSS 4-6.0
- Able to cycle on ergometer
You may not qualify if:
- A relapse of symptoms requiring treatment within the past three months.
- A respiratory condition that would be exacerbated by high intensity exercise including but not limited to: chronic obstructive pulmonary disorder, uncontrolled or poorly controlled asthma.
- Uncontrolled high pressure at screening (\>190/100 mmHg)
- Cognitive impairment affecting ability to understand instructions as noted in patient's notes.
- Currently engaging in another research trial for their MS or that may affect their physiological or cardiovascular outcomes
- Weighing more than 110 kg (weight limit of ergometer)
- Any pathology or medical intervention that would preclude high intensity exercise, maximal exertion testing or could attenuate the cardiovascular effect of exercise including but not limited to: unstable angina; diabetes; peripheral vascular disease or intermittent claudication; having a pace maker or medicine pump; surgical clips; having another neurological condition other than MS; and pregnancy. To be established from patient's notes and at screening session.
- A serious cardiovascular event in the past year including but not limited to: transient ischaemic attack, cerebrovascular event and myocardial infarction.
- Taking any of the following medication: beta blockers; vasodilators; ACE inhibitors; diuretics or any other medication that could cause exercise induced hypotension; hypoglycaemic insulin; metformin or other oral insulin medicine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Glasgowlead
- NHS Ayrshire and Arrancollaborator
- AKMcollaborator
Study Sites (1)
The University of Glasgow
Glasgow, G12 8LL, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
October 28, 2016
First Posted
November 1, 2016
Study Start
January 1, 2017
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
October 25, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share